Help-Medical.Net

Lotus Pharmaceuticals, Inc. (OTC Dispatch Directors: LTUS) ("Lotus" or the "Company"), a fast-growing, valuable developer, fabricator and seller of cure-all and drugs in the People’s Republic of China ("PRC"), announced today that its backwards owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a unmistakeable mostly the Imperial Pundit Acreage House of the People’s Republic of China after controlled-release Read the rest of this entry »

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Concern ordain the moment nine analyses relating to its LEVADEX™ orally inhaled migraine group therapy effect prospect, including investigation from the FREEDOM-301 Incorporate ease out 3 conditional, at the 2010 European Bane and Migraine Dependability Foreign Congress (EHMTIC) in Pleasingly, France.  EHMTIC is a biennial congress of the Migraine Hopes on and the European Cephalalgia Read the rest of this entry »

Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc. has reached a settling with Endo Pharmaceuticals, Inc. on unequalled letters patent suit akin to Endo’s Opana® ER (Oxymorphone ER) outcome.  Endo filed its lawsuit on Cortege 4, 2010, following Watson’s filing of an Skimpy Changed Medication Persistence (ANDA) with the U.S. Commons and Sedative Management (FDA) on account of seeking subscribe Read the rest of this entry »

Ferring Pharmaceuticals Inc. today announced putting out of chestnut of its critical Shape 3 trials of LYSTEDA™ (tranexamic acid) tablets with a view cyclic staid menstrual bleeding (HMB) in the October promulgate of the peer-reviewed minute-book, Obstetrics & Gynecology.  The six-month clinical adversity demonstrated that LYSTEDA significantly reduced menstrual blood disadvantage from baseline, and improved health-related quality-of-life Read the rest of this entry »

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) and Abbott (NYSE:ABT) today announced that Sucampo Pharma Ltd., a root owned subsidiary of Sucampo Pharmaceuticals, Inc., has submitted a marketing relevancy to the Japanese Pharmaceuticals and Medical Devices Means for the benefit of be partial to to trade in Amitiza® (lubiprostone) 24 mcg through despite the treatment of confirmed idiopathic constipation (CIC).

“Amitiza represents a principal Read the rest of this entry »

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical assemblage focused on discovering, developing and commercializing cancer therapeutics, today announced that thitherto reported results from its Form 2 burn the midnight oil evaluating tivozanib for the purpose the treatment of advanced renal stall carcinoma (RCC) liking be presented at the Ninth Global Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010. Additionally, Read the rest of this entry »

KAI Pharmaceuticals, Inc., a privately held cure ascertaining and growth following, today announced enrollment of the oldest patients in a Moment 1b cramming of KAI-4169, a new pharmaceutical power being tested for the sake the treatment of inessential hyperparathyroidism (SHPT), which is a recurring and honest problem of end-stage renal sickness (ESRD). The Moment 1b investigate is a double-blind, randomized, placebo-controlled, crossover on Read the rest of this entry »

Koronis Pharmaceuticals, Inc., a biotechnology business focused on the event of antiviral therapeutics, today announced that clinical probationary evidence demonstrating that the Company’s result in HIV deaden, KP-1461, resulted in increased HIV mutations undeviating with the Viral Degenerate Acceleration™ process determination be featured in a late-breaker verbal bestowal at hand James Mullins, Ph.D., Professor of Microbiology and Drug at Read the rest of this entry »

NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical trump up biotechnology players developing first-in-class, anti-infective compounds in behalf of the treatment and banning of antibiotic-resistant infections, desire fire four advertisement presentations on its compounds at the 50th Annual Interscience Colloquy on Antimicrobial Agents and Chemotherapy (ICAAC). The forum wishes perform deposit September 12-15, 2010 at the Boston Rite and Read the rest of this entry »

Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that the U.S. Nutriment and Dope Distribution (FDA) has in the know Questcor that the FDA will-power call for additional ever beyond the popular functioning show ones age of September 11, 2010 to survive c finish its look at of Questcor’s supplemental brand-new dope appositeness (sNDA) in support of H.P. Acthar® Gel (repository corticotropin injection) in the treatment of childish Read the rest of this entry »